Cat#:RP-1782H;Product Name:Recombinant Human Erythropoietin / EPO Protein ;Synonym:EPO, EP, Erythropoietin, Erythropoetin, Erthropoyetin, Hematopoietin, Hemopoietin, rhEPO, MVCD3;Source:HEK293;Molecular Characterization:Recombinant Human EPO / Erythropoietin protein has a calculated M.W. of 18.4 kDa. DTT-reduced protein migrates as 30-37 kDa estimated polypeptide in SDS-PAGE resulting from glycosylation. ;Purity:Greater than 97% as determined by SDS-PAGE.;Endotoxin:< 1.0 EU per μg of the recombinant human EPO protein by the LAL method.;Bioactivity:The bio-activity of recombinant human EPO protein was determined by dose-dependent stimulation of the proliferationof TF-1 cells ;Formulation:Recombinant human EPO protein was lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization;Stability:Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃;Reconstitution:Please see related COA for specific instructions.;Storage:Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -80℃).;